Edition:
United Kingdom

People: Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

102.62USD
22 Aug 2019
Change (% chg)

$-0.53 (-0.51%)
Prev Close
$103.15
Open
$103.30
Day's High
$103.50
Day's Low
$102.04
Volume
275,208
Avg. Vol
245,318
52-wk High
$111.52
52-wk Low
$78.97

Guinan, Mark 

Mr. Mark J. Guinan is Chief Financial Officer, Executive Vice President of the Company. Mr. Guinan joined the Company in July 2013. From 2010 until joining Quest Diagnostics in 2013, he served as Chief Financial Officer for Hill-Rom Holdings Inc., a manufacturer and provider of medical technologies and related services for the health care industry. Previously, he had served in a number of finance and operations roles in a long career at Johnson & Johnson including 2009 to 2010 as Vice President, Chief Procurement Officer, and 2005 to 2009 as Vice President, Group Finance Pharmaceuticals. Before joining Johnson & Johnson in 1997, he held a number of financial roles at Procter & Gamble.

Basic Compensation

Total Annual Compensation, USD 1,106,130
Restricted Stock Award, USD 1,380,020
Long-Term Incentive Plans, USD --
All Other, USD 974,243
Fiscal Year Total, USD 3,460,400

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stephen Rusckowski

10,348,000

Mark Guinan

3,460,400

James Davis

3,270,240

Gabrielle Wolfson

--

Michael Prevoznik

2,090,390

Jon Cohen

2,491,990
As Of  31 Dec 2017